Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 3 studies | 41% ± 15% | |
| interneuron | 3 studies | 45% ± 18% |
Insufficient scRNA-seq data for expression of PKD1L1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 95% | 84.24 | 20 / 21 | 25% | 0.98 | 128 / 504 |
| intestine | 98% | 78.91 | 947 / 966 | 14% | 0.24 | 76 / 527 |
| breast | 99% | 186.63 | 454 / 459 | 13% | 0.24 | 149 / 1118 |
| lung | 99% | 142.38 | 572 / 578 | 5% | 0.09 | 60 / 1155 |
| thymus | 98% | 157.69 | 637 / 653 | 4% | 0.07 | 25 / 605 |
| spleen | 100% | 65.20 | 241 / 241 | 0% | 0 | 0 / 0 |
| heart | 100% | 277.36 | 859 / 861 | 0% | 0 | 0 / 0 |
| adipose | 100% | 196.70 | 1199 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 99% | 121.61 | 795 / 803 | 0% | 0 | 0 / 0 |
| uterus | 96% | 67.98 | 164 / 170 | 2% | 0.05 | 10 / 459 |
| brain | 93% | 78.49 | 2458 / 2642 | 5% | 0.09 | 34 / 705 |
| esophagus | 84% | 105.06 | 1209 / 1445 | 9% | 0.16 | 17 / 183 |
| skin | 69% | 35.46 | 1246 / 1809 | 20% | 0.64 | 94 / 472 |
| stomach | 69% | 37.22 | 247 / 359 | 19% | 0.33 | 55 / 286 |
| ovary | 77% | 32.70 | 139 / 180 | 10% | 0.22 | 41 / 430 |
| prostate | 84% | 45.89 | 205 / 245 | 2% | 0.03 | 8 / 502 |
| kidney | 73% | 44.12 | 65 / 89 | 8% | 0.15 | 75 / 901 |
| blood vessel | 81% | 55.56 | 1084 / 1335 | 0% | 0 | 0 / 0 |
| adrenal gland | 32% | 11.83 | 82 / 258 | 19% | 0.29 | 44 / 230 |
| liver | 37% | 14.15 | 84 / 226 | 1% | 0.05 | 5 / 406 |
| pancreas | 31% | 10.88 | 101 / 328 | 3% | 0.40 | 6 / 178 |
| peripheral blood | 16% | 5.07 | 146 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 10% | 0.13 | 3 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0050982 | Biological process | detection of mechanical stimulus |
| GO_0070986 | Biological process | left/right axis specification |
| GO_0098609 | Biological process | cell-cell adhesion |
| GO_0003127 | Biological process | detection of nodal flow |
| GO_0070588 | Biological process | calcium ion transmembrane transport |
| GO_0060170 | Cellular component | ciliary membrane |
| GO_0097730 | Cellular component | non-motile cilium |
| GO_0005929 | Cellular component | cilium |
| GO_0034704 | Cellular component | calcium channel complex |
| GO_0016020 | Cellular component | membrane |
| GO_0005515 | Molecular function | protein binding |
| GO_0005262 | Molecular function | calcium channel activity |
| Gene name | PKD1L1 |
| Protein name | Polycystin-1-like protein 1 (Polycystin-1L1) (PC1-like 1 protein) (Polycystic kidney disease protein 1-like 1) Polycystin 1 like 1, transient receptor potential channel interacting |
| Synonyms | UNQ5785/PRO19563 |
| Description | FUNCTION: Component of a ciliary calcium channel that controls calcium concentration within primary cilia without affecting cytoplasmic calcium concentration. Forms a heterodimer with PKD2L1 in primary cilia and forms a calcium-permeant ciliary channel that regulates sonic hedgehog/SHH signaling and GLI2 transcription. Does not constitute the pore-forming subunit. Also involved in left/right axis specification downstream of nodal flow: forms a complex with PKD2 in cilia to facilitate flow detection in left/right patterning. . |
| Accessions | Q8TDX9 ENST00000289672.7 [Q8TDX9-1] A0A8I5QKU1 A0A3B3IRH7 ENST00000690269.1 ENST00000648482.1 ENST00000686775.1 ENST00000685709.1 A0A8I5KS31 H7C083 ENST00000433506.2 A0A8I5KWV8 |